Effect of Continuous Positive Airway Pressure Therapy on Glycemic Excursions and Insulin Sensitivity in Patients with Obstructive Sleep Apnea-hypopnea Syndrome and Type 2 Diabetes
查看参考文献23篇
文摘
|
Background: For patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) and type 2 diabetes mellitus (T2DM), the night sleep interruption and intermittent hypoxia due to apnea or hypopnea may induce glycemic excursions and reduce insulin sensitivity. This study aimed to investigate the effect of continuous positive airway pressure (CPAP) therapy in patients with OSAHS and T2DM. Methods: Continuous glucose monitoring system (CGMS) was used in 40 patients with T2DM and newly diagnosed OSAHS. The measurements were repeated after 30 days of CPAP treatment. Subsequently, insulin sensitivity and glycohemoglobin (HbAlc) were measured and compared to the pretreatment data. Results: After CPAP therapy, the CGMS indicators showed that the 24-h mean blood glucose (MBG) and the night time MBG were significantly reduced (P < 0.05 and P = 0.03, respectively). The mean ambulatory glucose excursions (MAGEs) and the mean of daily differences were also significantly reduced (P < 0.05 and P = 0.002, respectively) compared to pretreatment levels. During the night, MAGE also significantly decreased (P = 0.049). The differences between the highest and lowest levels of blood glucose over 24 h and during the night were significantly lower than prior to CPAP treatment (P < 0.05 and P = 0.024, respectively). The 24 h and night time durations of high blood glucose (>7.8 mmol/L and > 11.1 mmol/L) decreased (P < 0.05 and P < 0.05, respectively) after the treatment. In addition, HbAlc levels were also lower than those before treatment (P < 0.05), and the homeostasis model assessment index of insulin resistance was also significantly lower than before CPAP treatment (P = 0.034). Conclusions: CPAP therapy may have a beneficial effect on improving not only blood glucose but also upon insulin sensitivity in T2DM patients with OSAHS. This suggests that CPAP may be an effective treatment for T2DM in addition to intensive diabetes management. |
来源
|
Chinese Medical Journal
,2015,128(17):2301-2306 【核心库】
|
DOI
|
10.4103/0366-6999.163382
|
关键词
|
Continuous Glucose Monitoring System
;
Continuous Positive Airway Pressure
;
Obstructive Sleep Apnea-hypopnea Syndrome
;
Type 2 Diabetes Mellitus
|
地址
|
1.
Department of Endocrinology, Beijing Hospital, Beijing, 100730
2.
Department of General Medicine, First Hospital of China Medical University, Liaoning, Shenyang, 110001
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
0366-6999 |
学科
|
内科学;耳鼻咽喉科学 |
基金
|
supported by the grant from the Foundation of Beijing Municipal Science and Technology Commission
|
文献收藏号
|
CSCD:5507002
|
参考文献 共
23
共2页
|
1.
Resnick H E. Diabetes and sleep disturbances: Findings from the Sleep Heart Health Study.
Diabetes Care,2003,26:702-709
|
CSCD被引
17
次
|
|
|
|
2.
Einhorn D. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus.
Endocr Pract,2007,13:355-362
|
CSCD被引
9
次
|
|
|
|
3.
West S D. Prevalence of obstructive sleep apnoea in men with type 2 diabetes.
Thorax,2006,61:945-950
|
CSCD被引
20
次
|
|
|
|
4.
Sharafkhaneh A. Sleep apnea in a high risk population: A study of Veterans Health Administration beneficiaries.
Sleep Med,2004,5:345-350
|
CSCD被引
1
次
|
|
|
|
5.
Berry R B. Rules for scoring respiratory events in sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine.
J Clin Sleep Med,2012,8:597-619
|
CSCD被引
112
次
|
|
|
|
6.
Gruber A. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state.
Cardiovasc Diabetol,2006,5:22
|
CSCD被引
7
次
|
|
|
|
7.
Schahin S P. Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome.
Med Sci Monit,2008,14:CR117-CR121
|
CSCD被引
2
次
|
|
|
|
8.
Louis M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers.
J Appl Physiol (1985),2009,106:1538-1544
|
CSCD被引
10
次
|
|
|
|
9.
Stamatakis K A. Effects of sleep fragmentation on glucose metabolism in normal subjects.
Chest,2010,137:95-101
|
CSCD被引
19
次
|
|
|
|
10.
Wang X. Obstructive sleep apnoea and the risk of type 2 diabetes: A meta-analysis of prospective cohort studies.
Respirology,2013,18:140-146
|
CSCD被引
7
次
|
|
|
|
11.
Pamidi S. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial.
Am J Respir Crit Care Med,2015,192:96-105
|
CSCD被引
2
次
|
|
|
|
12.
Iftikhar I H. Meta-analyses of the association of sleep apnea with insulin resistance, and the effects of CPAP on HOMA-IR, adiponectin, and visceral adipose fat.
J Clin Sleep Med,2015,11:475-485
|
CSCD被引
6
次
|
|
|
|
13.
Pamidi S. Eight Hours of Nightly CPAP Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Prediabetes: A Randomized Controlled Trial.
Am J Respir Crit Care Med,2015(Epub ahead of print)
|
CSCD被引
1
次
|
|
|
|
14.
Dorkova Z. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome.
Chest,2008,134:686-692
|
CSCD被引
6
次
|
|
|
|
15.
Knutson K L. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus.
Arch Intern Med,2006,166:1768-1774
|
CSCD被引
9
次
|
|
|
|
16.
Shpirer I. Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment.
Sleep Breath,2012,16:461-466
|
CSCD被引
5
次
|
|
|
|
17.
Feng Y. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: A systematic review and meta-analysis.
NPJ Prim Care Respir Med,2015,25:15005
|
CSCD被引
5
次
|
|
|
|
18.
Torrella M. Intermittent hypoxia is an independent marker of poorer glycaemic control in patients with uncontrolled type 2 diabetes.
Diabetes Metab,2015(Epub ahead of print)
|
CSCD被引
1
次
|
|
|
|
19.
De Luca Canto G. Biomarkers associated with obstructive sleep apnea: A scoping review.
Sleep Med Rev, C,2014,23:28-45
|
CSCD被引
2
次
|
|
|
|
20.
Tatsumi K. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome.
Chest,2005,127:716-721
|
CSCD被引
8
次
|
|
|
|
|